Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Savara (SVRA)

Savara Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SVRA
DateTimeSourceHeadlineSymbolCompany
14/02/202521:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
14/02/202521:05Business WireSavara Announces New Employment Inducement GrantNASDAQ:SVRASavara Inc
14/02/202519:33Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SVRASavara Inc
11/02/202522:14Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SVRASavara Inc
30/01/202513:39Business WireSavara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open ResearchNASDAQ:SVRASavara Inc
29/01/202521:05Business WireSavara Announces Participation in Upcoming Healthcare Investor ConferencesNASDAQ:SVRASavara Inc
23/01/202521:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SVRASavara Inc
13/01/202513:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SVRASavara Inc
23/12/202421:05Business WireSavara Announces New Employment Inducement GrantNASDAQ:SVRASavara Inc
18/12/202421:05Business WireSavara Initiates Rolling Submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)NASDAQ:SVRASavara Inc
17/12/202421:05Business WireSavara Announces Participation in the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SVRASavara Inc
16/12/202423:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
16/12/202423:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
16/12/202423:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
16/12/202422:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
16/12/202422:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
16/12/202422:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
16/12/202422:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
16/12/202422:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
16/12/202422:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
16/12/202422:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
16/12/202422:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
16/12/202422:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SVRASavara Inc
16/12/202420:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SVRASavara Inc
16/12/202420:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SVRASavara Inc
27/11/202416:01Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SVRASavara Inc
22/11/202421:05Business WireSavara Announces New Employment Inducement GrantNASDAQ:SVRASavara Inc
22/11/202413:05Business WireSavara Announces Encore Presentation of Results from the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the British Thoracic Society Winter Meeting 2024NASDAQ:SVRASavara Inc
20/11/202412:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
18/11/202417:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
 Showing the most relevant articles for your search:NASDAQ:SVRA